UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e3606-e3614

2021

Link zum Volltext

Verfügbarkeit prüfen

Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial

Clinical infectious diseases, 2019-05, Vol.68 (12), p.1981-1989

2019

Link zum Volltext

Verfügbarkeit prüfen

Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999—2015

Clinical infectious diseases, 2017-07, Vol.65 (2), p.216-225

2017

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study

Clinical infectious diseases, 2019-04, Vol.68 (9), p.1463-1471

2019

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole Versus Itraconazole for the Initial and Step-down Treatment of Histoplasmosis: A Retrospective Cohort

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e3727-e3732

2021

Link zum Volltext

Verfügbarkeit prüfen

Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis

Clinical infectious diseases, 2020-02, Vol.70 (5), p.835-842

2020

Link zum Volltext

Verfügbarkeit prüfen

Substantial Impairment of Voriconazole Clearance by High-Dose Meropenem in a Patient With Renal Failure

Clinical infectious diseases, 2017-09, Vol.65 (6), p.1033-1036

2017

Link zum Volltext

Verfügbarkeit prüfen

Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole Versus Amphotericin B for Therapy of Invasive Aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group

Clinical infectious diseases, 2015-03, Vol.60 (5), p.713-720

2015

Link zum Volltext

Verfügbarkeit prüfen

Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients

Clinical infectious diseases, 2021-08, Vol.73 (3), p.416-426

2021

Link zum Volltext

Verfügbarkeit prüfen

Alopecia and nail changes associated with voriconazole therapy

Clinical infectious diseases, 2014-08, Vol.59 (3), p.e61-e65

2014

Link zum Volltext

Verfügbarkeit prüfen

Plasma Fluoride Level as a Predictor of Voriconazole-Induced Periostitis in Patients With Skeletal Pain

Clinical infectious diseases, 2014-11, Vol.59 (9), p.1237-1245

2014

Link zum Volltext

Verfügbarkeit prüfen

Complexity Interactions Between Nirmatrelvir/Ritonavir and Voriconazole in Patients With Coronavirus Disease 2019

Clinical infectious diseases, 2023-06, Vol.76 (12), p.2209-2210

2023

Link zum Volltext

Verfügbarkeit prüfen

Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions

Clinical infectious diseases, 2018-10, Vol.67 (10), p.1621-1630

2018

Link zum Volltext

Verfügbarkeit prüfen

Remarks on the Universal Lifelong Coccidioidomycosis Prophylaxis in Lung Transplant Recipients

Clinical infectious diseases, 2022-05, Vol.74 (10), p.1885-1886

2022

Link zum Volltext

Verfügbarkeit prüfen

Itraconazole and Voriconazole: The Complexity of Dose Adjustments

Clinical infectious diseases, 2022-08, Vol.75 (3), p.552-552

2022

Link zum Volltext

Verfügbarkeit prüfen

Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis

Clinical infectious diseases, 2017-06, Vol.64 (11), p.1619-1621

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies

Clinical infectious diseases, 2022-10, Vol.75 (9), p.1503-1510

2022

Link zum Volltext

Verfügbarkeit prüfen

Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France

Clinical infectious diseases, 2015-10, Vol.61 (8), p.1273-1280

2015

Link zum Volltext

Verfügbarkeit prüfen

A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study

Clinical infectious diseases, 2013-12, Vol.57 (12), p.e182-e188

2013

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole Dosing in Obese Patients

Clinical infectious diseases, 2016-07, Vol.63 (2), p.286-287

2016

Link zum Volltext

Verfügbarkeit prüfen

Combination Antifungal Therapy for Invasive Aspergillosis

Clinical infectious diseases, 2004-09, Vol.39 (6), p.797-802

2004

Link zum Volltext

Verfügbarkeit prüfen

Hallucinations during Voriconazole Therapy

Clinical infectious diseases, 2008-07, Vol.47 (1), p.e7-e10

2008

Link zum Volltext

Verfügbarkeit prüfen

An Unusual Etiology for Osteomyelitis in an Immunocompetent Host

Clinical infectious diseases, 2019-01, Vol.68 (2), p.343-345

2019

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole resistance in Aspergillus fumigatus: should we be concerned?

Clinical infectious diseases, 2013-08, Vol.57 (4), p.521-523

2013

Link zum Volltext

Verfügbarkeit prüfen

Invasive Zygomycosis in Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole Prophylaxis

Clinical infectious diseases, 2004-08, Vol.39 (4), p.584-587

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Zeitschrift / SerieClinical Infectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(61)
Immunology
(61)
Infectious Diseases
(61)
Life Sciences & Biomedicine
(61)
Microbiology
(61)
Science & Technology
(61)
Voriconazole
(58)
Antifungal Agents - Therapeutic Use
(38)
Triazoles - Therapeutic Use
(35)
Male
(31)
Pyrimidines - Therapeutic Use
(31)
Adult
(23)
Female
(23)
Middle Aged
(18)
Correspondence
(16)
Fungal Infections
(15)
Aged
(14)
Aspergillosis - Drug Therapy
(14)
Infections
(14)
Antifungal Agents - Adverse Effects
(12)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clin Infect Dis
(3)

Menü

Weitere Dienste

Einstellungen

Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study

Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial

Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999—2015

Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study

Voriconazole Versus Itraconazole for the Initial and Step-down Treatment of Histoplasmosis: A Retrospective Cohort

Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis

Substantial Impairment of Voriconazole Clearance by High-Dose Meropenem in a Patient With Renal Failure

Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients

Alopecia and nail changes associated with voriconazole therapy

Plasma Fluoride Level as a Predictor of Voriconazole-Induced Periostitis in Patients With Skeletal Pain

Complexity Interactions Between Nirmatrelvir/Ritonavir and Voriconazole in Patients With Coronavirus Disease 2019

Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions

Remarks on the Universal Lifelong Coccidioidomycosis Prophylaxis in Lung Transplant Recipients

Itraconazole and Voriconazole: The Complexity of Dose Adjustments

Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis

Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies

Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France

A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study

Voriconazole Dosing in Obese Patients

Combination Antifungal Therapy for Invasive Aspergillosis

Hallucinations during Voriconazole Therapy

An Unusual Etiology for Osteomyelitis in an Immunocompetent Host

Voriconazole resistance in Aspergillus fumigatus: should we be concerned?

Invasive Zygomycosis in Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole Prophylaxis

Aktive Filter

Suchergebnisse filtern